v3.25.2
Notes Payable - 2025 March Unsecured SPA Notes Narrative (Details)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
May 28, 2025
$ / shares
Mar. 21, 2025
USD ($)
day
closing
$ / shares
Jun. 30, 2025
USD ($)
$ / shares
shares
Jun. 30, 2024
USD ($)
Jun. 30, 2025
USD ($)
day
$ / shares
shares
Jun. 30, 2024
USD ($)
May 27, 2025
$ / shares
May 15, 2025
$ / shares
Mar. 31, 2025
USD ($)
Jan. 28, 2025
$ / shares
Dec. 31, 2024
USD ($)
$ / shares
Dec. 21, 2024
$ / shares
Jul. 31, 2024
$ / shares
Mar. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Debt Instrument [Line Items]                              
Exercise price (in dollars per share) | $ / shares                         $ 110,400    
Series B Preferred Stock                              
Debt Instrument [Line Items]                              
Pro rata aggregate cap (in shares) | shares     9,000,000   9,000,000                    
2024 Unsecured SPA Warrants                              
Debt Instrument [Line Items]                              
Debt instrument, term (in years)         5 years                    
Percent of purchaser's conversion shares     100.00%   100.00%                    
2024 Unsecured SPA Warrants | Class A Common Stock                              
Debt Instrument [Line Items]                              
Exercise price (in dollars per share) | $ / shares     $ 1.22   $ 1.22           $ 1.39        
Notes Payable                              
Debt Instrument [Line Items]                              
Notes and loans payable     $ 28,033 $ 77,394 $ 28,033 $ 77,394     $ 24,674   $ 49,488     $ 63,769 $ 91,150
Gain (loss) on fair value adjustment of debts     $ (8,723) (6,912) $ 13,057 20,809                  
2025 March Unsecured SPA Notes                              
Debt Instrument [Line Items]                              
Aggregate principal amount   $ 41,000                          
Debt instrument, number of closings | closing   4                          
Debt instrument, term (in years)   5 years                          
Contractual Interest Rates   10.00%                          
Debt instrument, redemption price, percentage   10.00%                          
Redemption price, percentage   25.00%                          
Conversion price (in dollars per share) | $ / shares   $ 1.29 $ 1.22   $ 1.22                    
Debt instrument, floor price (in dollars per share) | $ / shares   $ 1.048                          
Debt instrument, SPA waiver, term               45 days              
Debt instrument, SPA waiver, deferral period               20 days              
Share price (in dollars per share) | $ / shares               $ 1.00              
Debt instrument, convertible, threshold percentage of stock price trigger 100.00%                            
Debt instrument, exercisable, threshold percentage of stock price trigger 120.00%                            
Exercise price (in dollars per share) | $ / shares     $ 1.46   $ 1.46                    
2025 March Unsecured SPA Notes | Notes Payable                              
Debt Instrument [Line Items]                              
Debt instrument, term (in years)         5 years                    
Contractual Interest Rates   18.00% 10.00%   10.00%                    
Redemption price, percentage   8.00%                          
Debt instrument, convertible, threshold consecutive trading days (in days) | day   5                          
Notes and loans payable     $ 9,297   $ 9,297       763   $ 0        
Proceeds from debt, net of issuance costs     22,100   24,100                    
Debt conversion, converted amount     $ 6,800   $ 6,800                    
Shares issued from conversion (in shares) | shares     6,169,656   6,169,656                    
Gain (loss) on fair value adjustment of debts     $ (2,757)   $ (2,713)                    
2025 March Unsecured SPA Notes | Notes Payable | Class A Common Stock                              
Debt Instrument [Line Items]                              
Loss on settlement of notes payable     $ 5,500   $ 5,500                    
2024 Unsecured SPA Notes                              
Debt Instrument [Line Items]                              
Debt instrument, convertible, threshold consecutive trading days (in days) | day         1                    
Exercise price (in dollars per share) | $ / shares $ 1.22           $ 1.39                
2024 Unsecured SPA Notes | Notes Payable                              
Debt Instrument [Line Items]                              
Debt instrument, term (in years)         1 year                    
Contractual Interest Rates     10.00%   10.00%           10.00%        
Conversion price (in dollars per share) | $ / shares     $ 1.16   $ 1.16         $ 1.16   $ 1.16      
Debt instrument, floor price (in dollars per share) | $ / shares     $ 1.05   $ 1.05                    
Debt instrument, convertible, threshold consecutive trading days (in days) | day         5                    
Notes and loans payable     $ 10,009 0 $ 10,009 $ 0     $ 11,330   $ 7,032     $ 0  
Proceeds from debt, net of issuance costs     0   20,000                    
Gain (loss) on fair value adjustment of debts     (4,526) $ 0 2,272                    
2024 Unsecured SPA Notes | Notes Payable | Class A Common Stock                              
Debt Instrument [Line Items]                              
Debt conversion, converted amount     $ 11,700   $ 11,700                    
Shares issued from conversion (in shares) | shares     10,796,761   10,796,761                    
Loss on settlement of notes payable     $ 9,300   $ 9,300